Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
3 studies found for:    15236834 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives
Condition: Parkinson Disease
Intervention:
2 Not yet recruiting A Longitudinal Study in 1st Degree Relatives of Parkinson's Disease (PD) Patients
Condition: Parkinson's Disease
Intervention: Other: neurological examination
3 Unknown † Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics
Condition: Parkinson Disease
Intervention:
To Top

† Indicates status has not been verified in more than two years